Related Experiment Video
Updated: Sep 10, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
CARE-AD: a multi-agent large language model framework for Alzheimer's disease prediction using longitudinal clinical
Rumeng Li1,2, Xun Wang3, Dan Berlowitz2,4,5
1Manning College of Information & Computer Sciences, University of Massachusetts Amherst, Amherst, MA, USA.
A new multi-agent large language model (LLM) framework, CARE-AD, shows promise for predicting Alzheimer's disease (AD) onset using electronic health records. This approach improves early AD risk assessment accuracy compared to single-model methods.
Area of Science:
- Artificial Intelligence in Medicine
- Computational Neuroscience
- Clinical Informatics
Background:
- Large language models (LLMs) demonstrate potential across various fields but have limited application in complex clinical prediction.
- Early prediction of Alzheimer's disease (AD) is crucial for timely intervention and management.
Purpose of the Study:
- To introduce CARE-AD, a novel multi-agent LLM framework for forecasting Alzheimer's disease onset.
- To evaluate the efficacy of CARE-AD in analyzing longitudinal electronic health record (EHR) notes for early AD risk assessment.
Main Methods:
- Developed CARE-AD, a framework utilizing specialized LLM agents for extracting AD-relevant signs and symptoms from EHR notes.
- Emulated a collaborative diagnostic process by assigning domain-specific evaluation tasks to individual LLM agents.
- Conducted a retrospective evaluation comparing CARE-AD against baseline single-model approaches.
Main Results:
- CARE-AD achieved higher accuracy (0.53) in predicting AD risk 10 years prior to diagnosis compared to baseline models (0.26-0.45).
- The multi-agent system demonstrated superior performance in analyzing longitudinal EHR data for AD risk forecasting.
Conclusions:
- Multi-agent LLM systems are feasible for supporting early Alzheimer's disease risk assessment.
- CARE-AD's performance highlights the potential of integrating advanced AI into clinical decision support workflows for neurodegenerative diseases.
More Related Videos
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
08:43Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment